Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Fixed Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.811.131.321.160.93

What is the latest Fixed Capital/Sales ratio of NATCO PHARMA ?

The latest Fixed Capital/Sales ratio of NATCO PHARMA is 0.81 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.81
Mar20231.13
Mar20221.32
Mar20211.16
Mar20200.93

How is Fixed Capital/Sales of NATCO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.81
-28.32
Mar2023 1.13
-14.39
Mar2022 1.32
13.79
Mar2021 1.16
24.73
Mar2020 0.93 -

Other Financial Ratios of NATCO PHARMA


Compare Fixed Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,823.5 Cr 4.5% 7.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹125,156.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -0.8% -0.4% 0.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.5%

7.1%

-11.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses